🇬🇧·1d agoResearch
Author Correction: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial
Publisher
N
Nature Medicine
UK
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Nature Medicine
- Region
- UK
- Scope
- Research
- Published
- June 19, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on nature.com
Leave the platform to read the original full article on the publisher site.
Source: Nature Medicine
Scope: Research
Related coverage
More related coverage
UNMC/17h ago
MMI partners with Joslyn Castle to staff Carriage House Cafe
UNMC/18h ago
Garden Walk draws thousands for good cause
UNMC/18h ago
MMI Voices: Occupational therapy summer camps offer fun, friendship and skill building
Universitätsspital Zürich (USZ)/19h ago